Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Obes Sci Pract ; 5(5): 479-486, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31687172

RESUMO

OBJECTIVE: Weight perception and degree of confidence in achieving healthy lifestyle can be determinants of engagement in obesity interventions. This study explored patients' perceived need for weight loss and the degree of self-confidence in ability to lose weight and sought to identify factors associated with patients' self-confidence in ability to lose weight. METHODS: The authors analysed data from a survey mailed to primary care patients within five sites of the Learning Health Systems Network that explored participants' prior experience with weight management. RESULTS: Among the 2,263 participants who completed the survey section on 'Patients' Experience with Weight Management', perceived need to lose 51 lb or more was statistically significant among those with class III obesity compared with other body mass index (BMI) groups (p value < 0.001). Reported desire to lose weight was also significantly higher among those with the highest BMI than those who were overweight (p value < 0.001). However, this same group had the lowest belief in ability to lose weight (p value < 0.001). In a multiple regression analysis, female gender, higher BMI and need to lose >10 lb were each independently associated with less belief in being able to lose weight. CONCLUSIONS: Patients had varying perceptions on weight loss; those with category III obesity had the highest desire to lose weight but had the least confidence in ability to lose weight. Higher BMI, female gender and need to lose >10 lb were associated with decreased self-confidence in ability to lose weight.

3.
J Hand Surg Br ; 31(3): 331-3, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16580101

RESUMO

The purpose of this study was identification of the innervation of the medial humeral epicondyle which has not been described before. In 20 patients, the medial intermuscular septum was evaluated histopathologically: the nerve was identified in 15 specimens without S-100 staining, and in the remaining 5 with S-100 staining. In six fresh cadavers, bilateral dissections identified the source of this nerve as the radial nerve in the axilla, coursing adjacent to the ulnar nerve in the upper arm, then moving laterally to be superficial to, or within, the medial intermuscular septum, until the nerve terminated in the periosteum of the medial humeral epicondyle, at the origin of the flexor-pronator muscle mass. In one specimen, a branch from the ulnar nerve in the axilla contributed to this nerve to the medial humeral epicondyle.


Assuntos
Cotovelo/inervação , Úmero/inervação , Cadáver , Humanos , Nervo Radial/anatomia & histologia , Nervo Ulnar/anatomia & histologia
4.
J Med Chem ; 44(26): 4677-87, 2001 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-11741485

RESUMO

The synthesis and biological activities of biarylamide-substituted diaminoindanes as microsomal triglyceride transfer protein (MTP) inhibitors are described. One of the more potent compounds, 8aR, inhibited both the secretion of apoB from Hep G2 cells and the MTP-mediated transfer of triglycerides between synthetic acceptor and donor liposomes with IC(50) values of 0.7 and 70 nM, respectively. In normolipidemic rats and dogs, oral administration of 8aR dose-dependently reduced both plasma triglycerides and total cholesterol. Moreover, in rats and dogs, 8aR also prevented the postprandial rise in plasma triglycerides following a bolus administration of a fat load. Because MTP inhibitors decrease very low density lipoprotein assembly in the liver, the potential for hepatic lipid accumulation was evaluated. In normolipidemic rats, hepatic cholesterol and triglyceride contents were dose-dependently increased by 8aR. However, hepatic lipid accumulation resulted in negligible change in total liver weight and was reversible after withdrawal of the compound.


Assuntos
Benzamidas/síntese química , Proteínas de Transporte/antagonistas & inibidores , Glicerídeos/metabolismo , Hipolipemiantes/síntese química , Indanos/síntese química , Indenos/síntese química , Fígado/metabolismo , Animais , Apolipoproteínas B/metabolismo , Benzamidas/química , Benzamidas/farmacologia , Transporte Biológico , Colesterol/sangue , Cães , Glicerídeos/sangue , Hipolipemiantes/química , Hipolipemiantes/farmacologia , Indanos/química , Indanos/farmacologia , Indenos/química , Indenos/farmacologia , Espectroscopia de Ressonância Magnética , Microssomos Hepáticos/metabolismo , Período Pós-Prandial , Ratos , Estereoisomerismo , Relação Estrutura-Atividade , Células Tumorais Cultivadas
5.
J Cardiovasc Surg (Torino) ; 42(3): 359-64, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11398033

RESUMO

BACKGROUND: Currently the internal thoracic artery (ITA) is the conduit of preference for coronary artery revascularization. Although this artery offers several advantages over the saphenous vein there is a higher incidence of postoperative sternal wound infection with its use. This incidence further increases with the use of bilateral internal thoracic arteries (BITA). The use of muscle or omental flaps to treat this complication has significantly reduced the morbidity and mortality. Typically the pectoralis major (PM) or the rectus abdominis (RA) muscles are the preferred method of reconstruction of the infected sternotomy wound. METHODS: In a retrospective study over a four-year period from February 1994 to October 1998, nine patients underwent reconstruction of an infected median sternotomy wound with a latissimus dorsi myocutaneous flap (LDMF). RESULTS: All of the patients in our study were successfully treated with a single LDMF with the exception of one who required a rectus abdominis flap to cover the lateral aspect of the recalcitrant poststernotomy infected wound. There was a single patient who had a wound dehiscence at the donor site. CONCLUSIONS: The LDMF is reliable and serves as an adjunct for treating sternotomy infections. The flap provides sufficient amount of pedicle length and muscle mass for coverage. Although there is a need to turn the patient into a lateral decubitus position once the debridement is performed the flap harvest and its mobilization is technically straightforward with a short operative time, 135 minutes on average with a range of 97 to 171 minutes. Furthermore, there exists an anatomical advantage in using the LDMF; harvest of the LDMF does not disrupt collateral blood supply to the sternum and parasternal tissues.


Assuntos
Artérias/transplante , Ponte de Artéria Coronária , Esterno/cirurgia , Retalhos Cirúrgicos , Deiscência da Ferida Operatória/cirurgia , Infecção da Ferida Cirúrgica/cirurgia , Desbridamento , Estudos de Viabilidade , Seguimentos , Humanos , Reoperação , Fatores de Risco
6.
J Med Chem ; 38(10): 1689-700, 1995 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-7752193

RESUMO

The synthesis of three series of dicarboxylic acid dipeptide neutral endopeptidase 24.11 (NEP) inhibitors is described. In particular, the amino butyramide 21a exhibited potent NEP inhibitory activity (IC50 = 5.0 nM) in vitro and in vivo. Blood levels of 21a were determined using an ex vivo method by measuring plasma inhibitory activity in conscious rats, mongrel dogs, and cynomolgus monkeys. Free drug concentrations were 10-1500 times greater than the inhibitory constant for NEP over the course of a 6 h experiment. A good correlation of free drug concentrations was obtained when comparing values determined by the ex vivo analysis to those calculated from direct HPLC measurements. Plasma atrial natriuretic factor (exogenous) levels were elevated in rats and dogs after oral administration of 19a. Urinary volume and urinary sodium excretion were also potentiated in anesthetized dogs treated with 21a.


Assuntos
Ácidos Dicarboxílicos/farmacologia , Dipeptídeos/farmacologia , Neprilisina/antagonistas & inibidores , Sequência de Aminoácidos , Animais , Fator Natriurético Atrial/sangue , Fator Natriurético Atrial/farmacologia , Ácidos Dicarboxílicos/química , Ácidos Dicarboxílicos/farmacocinética , Dipeptídeos/química , Dipeptídeos/farmacocinética , Diurese/efeitos dos fármacos , Cães , Macaca fascicularis , Masculino , Dados de Sequência Molecular , Natriurese/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Relação Estrutura-Atividade
7.
J Med Chem ; 34(8): 2570-9, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1875349

RESUMO

A wide variety of 2-substituted aminoadenosines were prepared for comparison with the moderately A2 receptor selective adenosine agonist 2-anilinoadenosine (CV-1808). High selectivity combined with significant affinity at the A2 receptor in rat membranes was observed for those amines bearing a two-carbon chain to which was attached an aryl, heteroaryl, or alicyclic moiety. 2-(2-Phenethylamino)adenosine (3d), a 14-fold A2 selective compound, was modified by introduction of a variety of substituents in the benzene ring and the side chain. Some of these changes led to improved A2 affinity and increased selectivity. Replacement of the phenyl moiety by cyclohexenyl produced a 210-fold selective agonist 3ag (CGS 22989) whereas the cyclohexanyl analogue 3af (CGS 22492) was 530-fold selective at the A2 site. These compounds showed hypotensive activity in rat models over a range of doses without the bradycardia observed with less selective agonists.


Assuntos
Adenosina/análogos & derivados , Anti-Hipertensivos/síntese química , Receptores Purinérgicos/efeitos dos fármacos , Adenosina/síntese química , Adenosina/química , Adenosina/metabolismo , Adenosina/farmacologia , Adenosina/uso terapêutico , Alquilação , Animais , Anti-Hipertensivos/farmacologia , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Fenômenos Químicos , Química , Cicloexanos/síntese química , Cicloexanos/farmacologia , Cicloexanos/uso terapêutico , Frequência Cardíaca/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Masculino , Estrutura Molecular , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos , Receptores Purinérgicos/fisiologia
8.
J Arthroplasty ; 1(3): 165-8, 1986.
Artigo em Inglês | MEDLINE | ID: mdl-3559590

RESUMO

Samples of polymethylmethacrylate (PMMA) bone cement were polymerized in vitro with no additives and with the following additives: methylene blue dye, tobramycin, methylene blue plus tobramycin. After storage for 7 days in saline, samples were tested to failure in three-point bending. Addition of the antibiotic significantly weakened the cement (to 87% of control). However, the combination of tobramycin plus methylene blue was no weaker than tobramycin alone, suggesting that addition of both dye and antibiotic to bone cement is probably a reasonable clinical practice.


Assuntos
Cimentos Ósseos , Azul de Metileno , Metilmetacrilatos , Tobramicina , Estresse Mecânico
9.
Gastroenterology ; 74(5 Pt 1): 818-20, 1978 May.
Artigo em Inglês | MEDLINE | ID: mdl-640336

RESUMO

Three patients developed severe, incapacitating diarrhea after antibiotic administration. Presenting features included abdominal discomfort, hematochezia, and hypokalemia from voluminous diarrhea. Roetgenographic studies in 1 patient were normal and proctoscopic examinations in 2 patients failed to show antibiotic-associated colitis. Stool cultures were negative. Despite cessation of antibiotics and symptomatic therapy, the diarrhea continued. After the administration of oral tetracycline, the diarrhea stopped without recurrence even after the tetracycline was discontinued. These clinical results suggest that patients with antibiotic-associated diarrhea may benefit from tetracycline when standard medical therapy fails.


Assuntos
Antibacterianos/efeitos adversos , Diarreia/induzido quimicamente , Tetraciclina/uso terapêutico , Administração Oral , Idoso , Ampicilina/efeitos adversos , Cefalexina/efeitos adversos , Cefalotina/efeitos adversos , Clindamicina/efeitos adversos , Diarreia/tratamento farmacológico , Feminino , Gentamicinas/efeitos adversos , Humanos , Pessoa de Meia-Idade , Neomicina/efeitos adversos , Tetraciclina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA